Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Axsome Thera
(NQ:
AXSM
)
87.91
-0.25 (-0.28%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Axsome Thera
< Previous
1
2
...
12
13
14
15
16
17
18
19
Next >
Stocks That Hit 52-Week Lows On Friday
July 30, 2021
On Friday morning, 33 companies hit new 52-week lows. Areas of Significance: The largest company in terms of market cap to set a new 52-week low was Las Vegas Sands...
Via
Benzinga
Is There Any Hope Left for Axsome Therapeutics?
July 30, 2021
After a fantastic run-up, investors are now losing faith in this emerging biotech's stock.
Via
The Motley Fool
Why Shares of Axsome Therapeutics Are Falling Today
July 14, 2021
The FDA took back a beneficial designation but management isn't changing its plans.
Via
The Motley Fool
Exposures
Product Safety
Buy This Stock Before Everyone Else Does
July 14, 2021
This biotech has significant upside left.
Via
The Motley Fool
Thinking About Buying Stock In Immunome, Axsome Or Etsy?
April 26, 2021
Immunome Inc (NASDAQ:IMNM) shares are trading higher by 9.25% by $32.28 after the ...
Via
Benzinga
Ditch Dogecoin: These 3 Stocks Could Double Your Money
June 23, 2021
The path to a twofold or greater return is straightforward for each of these stocks.
Via
The Motley Fool
Axsome Therapeutics Targets Submission Of US Application For Fibromyalgia Candidate By 2022
June 15, 2021
After a pre-NDA meeting with FDA, Axsome Therapeutics Inc (NASDAQ: AXSM) has announced its plan to submit a marketing application seeking approval for AXS-14...
Via
Benzinga
Exposures
Product Safety
Benzinga's Top Ratings Upgrades, Downgrades For June 10, 2021
June 10, 2021
Upgrades According to Argus Research, the prior rating for Zoom Video Communications Inc (NASDAQ:ZM) was changed from Hold to Buy. Zoom Video Communications earned $1.32...
Via
Benzinga
2 Top Biotech Stocks to Buy for Summer 2021
June 05, 2021
Progress in these companies' drug development pipelines should give shareholders plenty to look forward to.
Via
The Motley Fool
Axsome Therapeutics, Inc. (AXSM) Q1 2021 Earnings Call Transcript
May 10, 2021
AXSM earnings call for the period ending March 31, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Parkinson’s Disease Therapeutic Market Revenue Is Expected To Cross $8 Billion By 2027
May 05, 2021
Via
FinancialNewsMedia
2 Top Biotech Stocks to Buy Right Now
April 30, 2021
The stocks of Novavax and Axsome Therapeutics are soaring. Here's why.
Via
The Motley Fool
Exposures
COVID-19
The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings
May 09, 2021
Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came...
Via
Benzinga
Exposures
COVID-19
Product Safety
3 Biotech Stocks That Could Be Millionaire-Makers
April 28, 2021
Their stocks have collapsed. But they could still be huge winners.
Via
The Motley Fool
58 Biggest Movers From Yesterday
April 27, 2021
Gainers Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) shares jumped 104.2% to close at $8.70 on Monday after the company announced the full details of its Phase 2 trial...
Via
Benzinga
Why Voyager Therapeutics, uniQure, Axsome, Reviva Pharma and Crispr Are Moving Today
April 26, 2021
Voyager Therapeutics, Inc. (NASDAQ: VYGR), uniQure N.V. (NASDAQ: QURE), Axsome Therapeutics, Inc. (NASDAQ: AXSM), Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) and CRISPR...
Via
Benzinga
Why Axsome Therapeutics Stock Is Jumping Today
April 26, 2021
The FDA granted Priority Review to the biotech's regulatory filing for its lead pipeline candidate.
Via
The Motley Fool
Exposures
Product Safety
38 Stocks Moving In Monday's Mid-Day Session
April 26, 2021
Gainers Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) surged 46.9% to $6.25 after the company announced the full details of its Phase 2 trial evaluating its lead drug...
Via
Benzinga
FDA Begins Priority Review of Axsome Therapeutics' Potential New Depression Drug
April 26, 2021
The first new treatment for millions of Americans with major depressive disorder could become available this summer.
Via
The Motley Fool
Exposures
Product Safety
Axsome Stock Jumps After Snagging Priority Review For Depression Drug
April 26, 2021
Axsome Therapeutics snagged a speedy review from the FDA for its depression treatment on Monday, leading Axsome stock to gap higher.
Via
Investor's Business Daily
Exposures
Product Safety
AXSM Stock: The Big FDA News Giving Axsome Therapeutics a Boost
April 26, 2021
AXSM stock is gaining on Monday after the FDA granted its new drug application priority review. Here's what you should know now.
Via
InvestorPlace
Exposures
Product Safety
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 26, 2021
Gainers Ocugen (NASDAQ:OCGN) shares rose 13.81% to $10.96 during Monday's pre-market session. The market value of their outstanding shares is at $2.0 billion. Advaxis...
Via
Benzinga
Axsome Therapeutics Stock Jumps As FDA Accepts AXS-05 Application In Major Depressive Disorder
April 26, 2021
Under Priority review status, the FDA has accepted Axsome Therapeutics Inc's (NASDAQ: AXSM) marketing application for AXS-05 for major depressive disorder (MDD...
Via
Benzinga
Exposures
Product Safety
Alzheimer's Disease: 5 Stocks on Biotech Radars
April 22, 2021
What's been interesting for the past couple of years, and especially the last few months, is to watch the rise of emerging, small-cap Biotech companies trying to take on the big AD and other...
Via
Talk Markets
The Daily Biotech Pulse: KemPharm Receives $10M Milestone Payment, Zymergen, Neuropace Debut On Nasdaq, Renalytix Wins US Government Contract, 2 IPOs
April 22, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 21) Alexion Pharmaceuticals,...
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
April 21, 2021
Wednesday morning, 25 companies reached new 52-week lows. Intriguing Points: Lufax Holding (NYSE:LU) was the biggest company by market cap to set a new 52-week low...
Via
Benzinga
The Daily Biotech Pulse: Moderna To Supply Variant-Specific Vaccine To Israel, Roche's Diagnostics Business Comes to Rescue
April 21, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 20) Alexion Pharmaceuticals,...
Via
Benzinga
The Daily Biotech Pulse: Novavax CFO Departs, Zai Lab Inks Cancer Drug Collaboration, FDA Nod For Gilead
April 14, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 13) Bio-Techne Corporation (...
Via
Benzinga
Exposures
Product Safety
Stocks That Hit 52-Week Lows On Monday
April 12, 2021
Before 10 a.m. ET on Monday, 30 stocks hit new 52-week lows. Interesting Highlights: The largest company by market cap to set a new 52-week low was Ionis Pharmaceuticals (...
Via
Benzinga
The Daily Biotech Pulse: Leadership Transition At Amarin, Vaccine Setback For J&J, FDA Nod For Label Expansion of Roche's Asthma Drug
April 13, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 12) 180 Life Sciences Corp. (...
Via
Benzinga
Exposures
Product Safety
< Previous
1
2
...
12
13
14
15
16
17
18
19
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.